Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy
Year: 2021
Type: article
Source: Clinical Lung Cancer
Institutions: AdventHealth Orlando, AdventHealth
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3161629183
